SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sara L. Best, Abhas Thapa, Neil Jackson, Ephrem Olweny, Michael Holzer, Samuel Park, Eleanor Wehner, Karel Zuzak, Jeffrey A. Cadeddu, Renal Oxygenation Measurement During Partial Nephrectomy Using Hyperspectral Imaging May Predict Acute Postoperative Renal Function, Journal of Endourology, 2013, 27, 8, 1037

    CrossRef

  2. 2
    Nicholas G. Cost, Mehrad Adibi, Jessica D. Lubahn, Adam Romman, Ganesh V. Raj, Arthur I. Sagalowsky, Vitaly Margulis, Effect of Testicular Germ Cell Tumor Therapy on Renal Function, Urology, 2012, 80, 3, 641

    CrossRef

  3. 3
    Edgar A.F. de Almeida, Carlota Lavinas, Catarina Teixeira, Mário Raimundo, Cristina Nogueira, Maria João Melo, Martina Ferreira, António Sampaio, Inês da Silva Henriques, Cecília Teixeira, Sofia Almeida, António Gomes da Costa, Miguel Leal, Evaluation of an Instrument for Screening Patients at Risk for Chronic Kidney Disease: Testing SCORED (Screening for Occult Renal Disease) in a Portuguese Population, Kidney and Blood Pressure Research, 2012, 35, 6, 568

    CrossRef

  4. 4
    Joshua Sleeper, Yair Lotan, Cost–effectiveness of robotic-assisted laparoscopic procedures in urologic surgery in the USA, Expert Review of Medical Devices, 2011, 8, 1, 97

    CrossRef

  5. 5
    Minato Yokoyama, Yasuhisa Fujii, Yasumasa Iimura, Kazutaka Saito, Fumitaka Koga, Hitoshi Masuda, Satoru Kawakami, Kazunori Kihara, Longitudinal Change in Renal Function After Radical Nephrectomy in Japanese Patients With Renal Cortical Tumors, The Journal of Urology, 2011, 185, 6, 2066

    CrossRef

  6. 6
    Max Kates, Gina M. Badalato, James M. McKiernan, Renal functional outcomes after surgery for renal cortical tumors, Current Opinion in Urology, 2011, 21, 5, 351

    CrossRef

  7. 7
    Jeremiah J. Morrissey, Amy N. London, Matthew C. Lambert, Evan D. Kharasch, Sensitivity and Specificity of Urinary Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 for the Diagnosis of Renal Cell Carcinoma, American Journal of Nephrology, 2011, 34, 5, 391

    CrossRef

  8. 8
    Paul Russo, Editorial Comment, Urology, 2010, 76, 3, 642

    CrossRef

  9. 9
    Joaquim Bellmunt, Mayer Fishman, Timothy Eisen, David Quinn, Expert opinion on the use of first-line sorafenib in selected metastatic renal cell carcinoma patients, Expert Review of Anticancer Therapy, 2010, 10, 6, 825

    CrossRef

  10. 10
    Paul Russo, Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization, BJU International, 2010, 105, 11
  11. 11
    Steven M. Lucas, Jeffrey A. Cadeddu, The Importance of Nephron-Sparing Focal Therapy: Renal Function Preservation, Journal of Endourology, 2010, 24, 5, 769

    CrossRef

  12. 12
    H. Bang, M. Mazumdar, G. Newman, A. S. Bomback, C. M. Ballantyne, A. S. Jaffe, P. A. August, A. V. Kshirsagar, Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience, Nephrology Dialysis Transplantation, 2009, 24, 8, 2452

    CrossRef

  13. 13
    A.S. Kibel, The Screening for Occult Renal Disease (SCORED) Value Is Associated With a Higher Risk for Having or Developing Chronic Kidney Disease in Patients Treated for Small, Unilateral Renal Masses, Yearbook of Urology, 2009, 2009, 107

    CrossRef

  14. 14
    Obi Ekwenna, Rajan Ramanathan, Raymond J. Leveillee, Percutaneous Radiofrequency Ablation of Kidney Tumors,